Medications like Wegovy and Zepbound have helped many people manage their weight, but the idea of giving yourself weekly injections can feel intimidating
A recent meta-analysis encompassing 11 observational and case-control studies across various countries revealed no statistically significant disparity in suicidal outcomes between GLP-1 RA users and those utilizing alternative antihyperglycemic medications (relative risk, 0.57
The trial uncovered no safety red flags during its duration, but the limited follow-up and relatively homogenous patient population indicate there is more work to be done
Like Ro, other non-drugmakers, including Calibrate, Sesame, Omada Health, Noom, Hims & Hers and even telehealth industry veterans Teladoc Health and WeightWatchers, have rolled out offerings geared toward patients on GLP-1s, or have expanded their services to include the popular medications
This does not mean the medication was a failure
It works on the same GLP-1 receptor as Ozempic, but you swallow it daily instead of injecting weekly